Literature DB >> 1087595

Lymphocyte response to IgG in patients with ankylosing spondylitis and their families.

R H Weisbart, R I Morris, P I Terasaki, R Bluestone, L S Goldberg.   

Abstract

Lymphocyte responsiveness to IgG was measured by an agarose method in nine patients with ankylosing spondylitis (AS), one patient with Reiter's Syndrome (RS), and thirty-six of their family members. Similar studies were also performed in five patients with rheumatoid arthritis (RA) and twenty-nine of their first degree relatives as well as in seven control families (twenty-seven subjects). Lymphocytes from the ten spondylitic patients and twenty-four of thirty-six family members responded in vitro to autologous IgG. Although most of these subjects had the histocompatibility antigen, B27, there was no association between B27 and response to IgG. Four of the five patients with RA and twenty of their twenty-nine first degree relatives responded in vitro to IgG, whereas only six of twenty-seven control family members gave a positive reaction. There was no difference in the incidence of antiglobulins (detected by agglutination tests) in the family members of patients with AS and RA or in control family members. These data indicate that lymphocyte responsiveness to IgG is the only aberrant immune response thus far described which is shared by patients with AS and RA and their family members.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1087595      PMCID: PMC1540978     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  A modified agarose method for detection of migration inhibitory factor and delineation of its antigen dependency.

Authors:  R H Weisbart; J E Cunningham; R Bluestone; L S Goldberg
Journal:  Int Arch Allergy Appl Immunol       Date:  1973

2.  Ankylosing spondylitis and HL-A 27.

Authors:  D A Brewerton; F D Hart; A Nicholls; M Caffrey; D C James; R D Sturrock
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

3.  IgG antiglobulin levels in patients with psoriatic arthropathy, ankylosing spondylitis, and gout.

Authors:  F A Howell; M A Chamberlain; R A Perry; G Torrigiani; I M Roitt
Journal:  Ann Rheum Dis       Date:  1972-03       Impact factor: 19.103

4.  Migration enhancement factor: a new lymphokine.

Authors:  R H Weisbart; R Bluestone; L S Goldberg; C M Pearson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205

5.  HL-A-linked human immune-response genes.

Authors:  C E Buckley; F C Dorsey; R B Corley; W B Ralph; M A Woodbury; D B Amos
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

6.  Migration inhibitory effect of cell-free supernatants from tuberculin-stimulated cultures of human mononuclear leukocytes demonstrated by two-step MIF agarose assay.

Authors:  J E Clausen
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

7.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

8.  A simplified method for lymphocyte separation.

Authors:  R H Weisbart; W F Webb; R Bluestone; L S Goldberg
Journal:  Vox Sang       Date:  1972       Impact factor: 2.144

9.  Immunochemical properties of human gamma-A isohemagglutinin. I. Comparisons with gamma-G and gamma-M-globulin antibodies.

Authors:  K Ishizaka; T Ishizaka; E H Lee; H Fudenberg
Journal:  J Immunol       Date:  1965-08       Impact factor: 5.422

10.  Ragweed hay fever: genetic control and linkage to HL-A haplotypes.

Authors:  B B Levine; R H Stember; M Fotino
Journal:  Science       Date:  1972-12-15       Impact factor: 47.728

View more
  1 in total

1.  Detection of immune complexes in serum of patients with ankylosing spondylitis.

Authors:  V Corrigall; G S Panayi; A Unger; R N Poston; B D Williams
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.